Story

Lifco Shares Rise on Strong H1 Profit Growth and Margin Expansion

ENTHMSVIIDZHZH-TWJAKOHI
Jul 14, 20261 min read
Lifco Shares Rise on Strong H1 Profit Growth and Margin Expansion

Summary

The Swedish industrial conglomerate reported a 10.1% increase in first-half operating profit and expanded its EBITA margin to 22.6%, supported by both organic growth and acquisitions.

Text size
Background

Shares of Swedish industrial conglomerate Lifco (LIFCOb) gained 2.7% on Tuesday after the company released strong first-half 2026 results, reporting double-digit profit growth and an expansion in operating margins.

Strong First-Half Performance

Lifco reported that its operating profit before amortization (EBITA) for the first six months of the year rose 10.1% compared to the same period a year earlier. The company's EBITA margin also improved, expanding to 22.6% from 22.0%.

The positive results were driven by solid top-line growth, with net sales climbing 7.2% to 14.88 billion Swedish crowns. This increase was composed of 2.9% in organic growth and a 7.1% contribution from recent acquisitions. Net profit for the first half increased 12.8% to 1.94 billion crowns.

Acquisitions and Balance Sheet Strength

Acquisitions remain a core part of Lifco's strategy. During the first half, the company completed four acquisitions with combined annual sales of approximately 500 million crowns: Britain’s Ethoss Regeneration and Glass Umbrella, Germany’s Karl Kaps, and Italy’s Metalltech.

Sample IUX Markets – In-articleAd

Lifco's capacity for further deal-making is supported by a strong balance sheet. As of June 30, its interest-bearing net debt stood at 1.2 times EBITDA, well below the company's internal target ceiling of three times EBITDA. This low leverage provides significant financial headroom for future acquisitions.

Segment Details and Market Context

The company's performance was not uniform across all divisions. The Demolition & Tools segment was a weak point, with first-half sales declining 0.8% and EBITA falling 6.2% due to an unfavorable product mix driven by weak demand for demolition robots.

Lifco's share price advance occurred despite a soft broader market in Stockholm and negative sentiment from the prior U.S. trading session. The company's strong fundamentals, combined with a supportive analyst view from SEB, which recently raised its price target to SEK 360, appeared to outweigh the macroeconomic headwinds.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST